Why Legend Biotech Stock Crushed the Market on Monday [Globe and Mail, The (Toronto, Canada)]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Globe and Mail, The
Legend has innovative science backing its oncology drug development efforts. Legend Biotech (NASDAQ: LEGN) was one of the healthier healthcare stocks on the market as the trading week kicked off on Monday. Not one, but two, bullish analyst updates helped propel the biotech stock to a sturdy 18% gain on Monday, a performance that sharply contrasted with the 0.2% slump of the S&P 500 index. A pharmaceutical giant swoops That morning, both H.C. Wainwright's Mitchell Kapoor and RBC Capital's Leonid Timashev reiterated their equivalents of buy recommendations on Legend. Of the pair, Timashev is the more bullish, as his price target is $62 per share, while Kapoor's is $50. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Image source: Getty Images. According to reports, the RBC prognosticator was inspired by E
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- Legend Biotech: Undervalued Leader In The CAR-T Race [Seeking Alpha]Seeking Alpha
- Legend Biotech CARVYKTI Milestones Contrast With Mixed Long Term Share Returns [Yahoo! Finance]Yahoo! Finance
- Legend Biotech (LEGN) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.MarketBeat
- Why Legend Biotech Stock Crushed the Market on Monday [Yahoo! Finance]Yahoo! Finance
- Is Legend Biotech (LEGN) One of the Overlooked Growth Stocks to Buy Now? [Yahoo! Finance]Yahoo! Finance
LEGN
Sec Filings
- 4/14/26 - Form 6-K
- 3/27/26 - Form 4
- 3/26/26 - Form 144
- LEGN's page on the SEC website